Alas-as, Ian L.
HRN: 26-12-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/30/2024
11/06/2024
IV
1.5g
Q6h
Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes